Specgx Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPECGX LLC, and what generic alternatives to SPECGX LLC drugs are available?
SPECGX LLC has sixty-one approved drugs.
There is one US patent protecting SPECGX LLC drugs.
There are ten patent family members on SPECGX LLC drugs in nine countries and thirty supplementary protection certificates in ten countries.
Summary for Specgx Llc
International Patents: | 10 |
US Patents: | 1 |
Tradenames: | 47 |
Ingredients: | 31 |
NDAs: | 61 |
Drug Master File Entries: | 73 |
Drugs and US Patents for Specgx Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specgx Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 076353-002 | May 6, 2003 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Specgx Llc | OXYMORPHONE HYDROCHLORIDE | oxymorphone hydrochloride | TABLET;ORAL | 202321-001 | Apr 25, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Specgx Llc | METHYLIN | methylphenidate hydrochloride | SOLUTION;ORAL | 021419-001 | Dec 19, 2002 | AA | RX | Yes | Yes | 7,691,880 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Specgx Llc | OXYCET | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 087463-001 | Dec 7, 1983 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Specgx Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Specgx Llc | EXALGO | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021217-001 | Mar 1, 2010 | 5,702,725 | ⤷ Try a Trial |
Specgx Llc | RESTORIL | temazepam | CAPSULE;ORAL | 018163-003 | Oct 25, 1991 | 5,326,758 | ⤷ Try a Trial |
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-004 | Approved Prior to Jan 1, 1982 | 3,922,305 | ⤷ Try a Trial |
Specgx Llc | EXALGO | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021217-004 | Aug 24, 2012 | 5,702,725 | ⤷ Try a Trial |
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-003 | Approved Prior to Jan 1, 1982 | 3,922,305 | ⤷ Try a Trial |
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-001 | Approved Prior to Jan 1, 1982 | 3,922,305 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SPECGX LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 5 mg/5 mL and 10 mg/5 mL | ➤ Subscribe | 2010-04-13 |
International Patents for Specgx Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 4959335 | ⤷ Try a Trial |
Spain | 2373042 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2005035000 | ⤷ Try a Trial |
Austria | 526988 | ⤷ Try a Trial |
European Patent Office | 1680144 | ⤷ Try a Trial |
Canada | 2540052 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Specgx Llc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0975367 | 122011000009 | Germany | ⤷ Try a Trial | PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831 |
2316456 | 2017C/064 | Belgium | ⤷ Try a Trial | PRODUCT NAME: NALTREXONE/BUPROPION; AUTHORISATION NUMBER AND DATE: EU/1/14/988 20150330 |
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
0383579 | C960030 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: REMIFENTANYLUM, DESGEWENST IN DE VORM VAN EEN ZUURADDITIE-ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 20601 - RVG 20603 19961015; 36335.00.00, 36335.01.00, 36335.02.00 19960517 |
2316456 | 17C1058 | France | ⤷ Try a Trial | PRODUCT NAME: NALTREXONE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER CHLORHYDRATE DE NALTREXONE ET,BUPROPION OU SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER CHLORHYDRATE DE BUPROPION; REGISTRATION NO/DATE: EU/1/14/988 20150330 |
1635783 | CA 2014 00016 | Denmark | ⤷ Try a Trial | PRODUCT NAME: FENTANYL I EN HVILKEN SOM HELST AF DE FORMER, DER ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/10/644/001-006 20100831 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.